Okta, Inc. <OKTA.O>: Mizuho Raises Target Price to $145 From $125
OKTA•Related News
Kiora Pharma licenses South Korea rights for KIO-301 to Chong Kun Dang in $1 million deal
KPRX•
Merck, Moderna Say Melanoma Skin Cancer Treatment Meets Main Goal In Late-Stage Trial
MRK•
Palo Alto Networks, Inc. <PANW.O>: Stifel Raises Target Price to $415 From $330
PANW•
Abercrombie & Fitch Co. <ANF.N>: Telsey Advisory Group Raises Target Price to $118 From $115
ANF•
Intuit <INTU.O>: Deutsche Bank cuts target price to $425 from $530
INTU•